Laparoscopic Partial Nephrectomy

My Clinical Approach

In a kidney tumour, the most important question before surgery is not only whether the tumour can be removed, but whether it can be removed safely while preserving the kidney.

Suitability for partial nephrectomy is not determined by size alone, but by tumour anatomy, its relationship to vessels and the collecting system, the function of both kidneys, and surgical complexity.

• I always consider first whether partial nephrectomy is technically and oncologically feasible.
• I do not use a magic cut-off in centimetres or minutes of ischaemia.
• My goal is complete tumour removal with maximal preservation of functioning kidney tissue.
• I explain clearly that the laparoscopic technique does not guarantee an outcome and does not eliminate the risk of complications.
• I do not promise unchanged kidney function or zero risk of recurrence.

What Is Partial Nephrectomy

In partial nephrectomy, the kidney tumour is removed together with the necessary margin of healthy tissue, while the rest of the kidney remains in place.

The goals are:

• Complete tumour removal.
• Negative surgical margin where achievable.
• Maximum preservation of functioning renal parenchyma.
• Safe reconstruction of the kidney.

Partial Nephrectomy ≠ Biopsy

Why Preserve the Kidney

Preservation of renal parenchyma may reduce the loss of kidney function compared with radical nephrectomy.

This has particular importance in:

• Chronic kidney disease.
• Hypertension.
• Diabetes.
• Solitary kidney.
• Bilateral tumours.
• Younger patients with greater lifetime renal risk.

We do not promise that kidney function will remain exactly the same.

T1 Kidney Tumours

We do not create a rule that every T1a must always be treated with partial nephrectomy, or that every T1b always needs radical nephrectomy.

T2 Kidney Tumours

Selected larger tumours may be treated with partial nephrectomy in:

• Expert centres.
• Favourable anatomy.
• Imperative indications (solitary kidney, bilateral disease).
• Chronic kidney disease.

when oncologically/technically appropriate. We do not present partial nephrectomy for T2 tumours as a routine solution for everyone.

Size Is Not the Only Criterion

Also relevant:

• Location.
• Exophytic/endophytic character.
• Depth.
• Proximity to the renal hilum.
• Relationship to the collecting system.
• Relationship to the vessels.
• Multifocality.
• Kidney function.
• Surgeon experience.

How Complex Is a Kidney Tumour?

Tools such as the RENAL nephrometry score and the PADUA classification can be used to describe the anatomical complexity of a kidney tumour, taking into account features such as:

• Size.
• Depth.
• Proximity to the collecting system.
• Polar location.
• Relationship to the renal hilum.

Exophytic vs Endophytic Tumour

Endophytic lesions may be technically more complex, but this does not automatically contraindicate partial nephrectomy.

Can Partial Nephrectomy Be Done for a Tumour Near the Vessels?

Hilar tumours may be more demanding due to proximity to:

• Branches of the renal artery.
• The renal vein.
• The collecting system.

But hilar location does not automatically mean radical nephrectomy. Expertise matters.

Central/Complex Tumours

Complex anatomy may increase:

• Operative complexity.
• Bleeding risk.
• The likelihood of entering the collecting system.
• Reconstruction requirements.
• Ischaemic burden.

but does not necessarily preclude partial surgery.

Solitary Kidney

Treatment strategy must take into account:

• Baseline eGFR.
• Tumour complexity.
• Malignancy risk.
• Dialysis risk.
• Alternatives.
• Technical feasibility.

We do not write that partial nephrectomy is always possible.

Bilateral/Multifocal Tumours

Partial nephrectomy has an important role in selected bilateral or multifocal tumours, as well as in hereditary kidney cancer syndromes, with the aim of preserving kidney tissue.

Hereditary Kidney Cancer

Selected hereditary syndromes may be associated with bilateral, recurrent, or multifocal tumours and may require a long-term nephron-sparing strategy. This page is not a genetics guide — genetic assessment is individualised.

Partial vs Radical Nephrectomy

See also the “When Is Radical Nephrectomy Needed” section on the 3D laparoscopic radical nephrectomy page.

Oncological Effectiveness

In appropriately selected localised tumours, partial nephrectomy aims for oncological control while preserving kidney tissue.

Laparoscopic vs Robotic Partial Nephrectomy

The robotic platform can facilitate some technically demanding steps of intracorporeal reconstruction, but this does not mean that a properly performed laparoscopic partial nephrectomy is oncologically inferior. No approach is presented as the “winner”. See also robotic partial nephrectomy.

Laparoscopic vs Open Partial Nephrectomy

Open partial nephrectomy remains important in selected very complex tumours, extensive multifocal disease, challenging anatomy, or situations where direct exposure is advantageous. We do not present open surgery as outdated.

What Laparoscopic Surgery Means

The surgeon directly manipulates the laparoscopic instruments through small incisions, viewing the procedure on a monitor via a camera that may offer 2D or, where available, stereoscopic 3D vision.

3D Laparoscopy vs Robotic Surgery

Both approaches are minimally invasive, fully controlled by the surgeon, and depend heavily on team expertise. 3D laparoscopy is not robotic surgery, and stereoscopic vision alone does not guarantee a superior oncological outcome.

Why 3D Imaging Matters in Partial Nephrectomy

Partial nephrectomy requires a combination of tumour excision, vascular management, collecting-system repair when needed, and renal reconstruction/suturing.

Stereoscopic three-dimensional vision, where available, can facilitate depth perception and identification of anatomical structures during minimally invasive reconstruction. The technology does not guarantee the outcome.

Preoperative Imaging

Contrast-enhanced multiphasic CT or MRI can assess:

• Tumour size.
• Location.
• Depth.
• Arterial anatomy.
• Venous anatomy.
• Relationship to the collecting system.
• The contralateral kidney.
• Metastatic disease where relevant.

We do not claim that every case requires identical imaging.

Is a Biopsy Needed Before Partial Nephrectomy?

Biopsy can be particularly useful when:

• Pathology may change management.
• Active surveillance is being considered.
• Ablation is planned.
• Diagnosis is uncertain.
• Systemic treatment is contemplated.

If surgery is clearly indicated for a suspicious, resectable renal mass, biopsy is not always required.

Small Tumour ≠ Automatic Surgery

We do not give a universal growth-rate threshold or imaging interval without current verification.

How the Procedure Is Performed

This description is deliberately kept at a general level — it is not a surgical manual with clamping technique, trocar placement sequence, suturing sequence, or device details.

Why Blood Flow to the Kidney Is Temporarily Interrupted

In many partial nephrectomies, temporary clamping of the renal arterial inflow may be needed to:

• Control bleeding.
• Correctly identify the tumour.
• Allow safe reconstruction.

This creates temporary warm ischaemia.

Warm Ischaemia Time

The modern interpretation emphasises that the kidney-function outcome depends on:

• Baseline kidney function.
• The amount/quality of preserved parenchyma.
• Tumour complexity.
• The duration of ischaemia.
• The type/extent of vascular clamping.
• Patient factors.

“Every minute counts” should not be used as a marketing slogan without nuance — a shorter ischaemia time can be advantageous, but safe tumour removal, haemostasis, or reconstruction should not be sacrificed to achieve an arbitrary number of minutes.

Off-Clamp & Selective Clamping

Off-clamp is not automatically better. The goal is safe oncological surgery with maximal kidney preservation — not simply “zero minutes” of ischaemia at any cost. Evidence does not support a universal superiority of off-clamp surgery.

Resection or Tumour Enucleation

Different surgical strategies include:

• Standard resection with a narrow margin of healthy parenchyma.
• Enucleoresection.
• Tumour enucleation in selected cases.

depending on the tumour’s pseudocapsule, anatomy, pathology suspicion, and surgical strategy. We do not present a “wide centimetre margin” as a requirement.

Surgical Margins

Modern partial nephrectomy does not require an arbitrarily wide healthy-tissue margin. We do not state that a 1 cm margin, or any other specific measurement, is mandatory without supporting evidence.

What Happens If the Histology Shows a Positive Surgical Margin?

Management may include:

• Risk assessment.
• Closer surveillance.
• Consideration of additional treatment only in selected contexts.

based on pathology, tumour biology, margin context, imaging, and recurrence risk. Frozen section is not used routinely in every partial nephrectomy — its use is selective. We do not cause unnecessary fear.

Kidney Reconstruction (Renorrhaphy)

After excision, the kidney is reconstructed — this includes control of bleeding, repair of the collecting system where required, and reconstruction of the renal tissue. We do not give suturing technique.

Urine Leak

Deep/central tumours may communicate with the kidney’s collecting system, which may require repair during surgery. Urine leak can occur postoperatively, particularly if:

• The collecting system was opened during surgery.
• The tumour was deep/central.
• Reconstruction was complex.

Management varies according to severity and may include observation, drainage, a ureteral stent in selected cases, or rarely further intervention. It is not automatically a serious complication in every case.

Delayed Bleeding & Pseudoaneurysm

Delayed haemorrhage can present with:

• Haematuria.
• Flank pain.
• Haemoglobin drop.
• Haemodynamic symptoms.

A rare cause of delayed bleeding is a renal artery pseudoaneurysm or an arteriovenous fistula, which can sometimes be treated with selective angiographic embolisation. This needs prompt medical assessment.

Could the Whole Kidney Need to Be Removed After All?

Intraoperative findings may require conversion to radical nephrectomy for:

• Oncological safety.
• Uncontrollable bleeding.
• Unexpected anatomy.
• Inability to preserve a functioning kidney safely.

This is a safety/oncological decision, not automatically a surgical failure.

Conversion to Open Surgery

Likewise, conversion to open surgery may be required for bleeding, difficult anatomy, oncological concerns, or safety. Not a failure.

Kidney Function After the Procedure

Postoperative kidney function depends on:

• Baseline eGFR.
• The amount of preserved functioning parenchyma.
• Tumour complexity.
• Ischaemic injury.
• Age.
• Diabetes.
• Hypertension.
• Pre-existing CKD.

We do not promise unchanged creatinine/eGFR.

Parenchymal Preservation

We do not present ischaemia time as the sole determinant of kidney function.

Chronic Kidney Disease

In patients with pre-existing CKD, nephron preservation is particularly valuable, perioperative renal assessment is essential, and nephrology involvement may be appropriate. We do not make blanket statements.

Might I Need Dialysis?

The risk can be relevant in a solitary kidney, advanced CKD, severe bilateral disease, or perioperative renal injury. We do not give a zero-risk guarantee.

Preoperative Assessment

• Multiphasic CT/MRI.
• Tumour complexity.
• Kidney function.
• Contralateral kidney.
• Full blood count.
• Biochemical/metabolic profile.
• Urinalysis when appropriate.
• Medications.
• Anticoagulants.
• Anaesthetic review.
• Cardiovascular risk.
• Diabetes/hypertension.
• Previous surgery.
• Biopsy where clinically relevant.

Anticoagulants & Anaesthesia

Laparoscopic partial nephrectomy is performed under general anaesthesia, in an operating-room setting.

Duration & Hospital Stay

There is no universal operating time. It depends on tumour complexity, hilar anatomy, the number of tumours, obesity, adhesions, previous surgery, the need for reconstruction, and surgical strategy.

Hospital stay is also variable and depends on complexity, recovery, pain, kidney function, bleeding, urine leak, and centre protocol. We do not promise a fixed number of days.

Recovery & Timeline

Covers mobilisation, oral intake, pain control, wound care, fatigue, return to work, driving, exercise, and kidney-function monitoring. We prefer healing-based advice over rigid timetables.

When Immediate Evaluation Is Needed

Possible Complications

Pathology & RCC Subtypes

The pathology report can establish whether the tumour is benign or malignant, the RCC subtype, tumour size, pathological stage, grade where applicable, margin status, and other prognostic features, using current WHO terminology.

Common RCC subtypes include clear-cell, papillary, and chromophobe RCC.

Follow-Up & Prognosis

Partial nephrectomy does not guarantee zero recurrence risk. Risk depends on stage, tumour biology, grade, multifocality, hereditary context, and margin status. In selected local recurrence, management may include repeat partial surgery, radical nephrectomy, ablation, or another individualised approach.

In high-risk RCC, adjuvant systemic therapy may be considered in selected patients, according to current EAU/ESMO/NCCN guidance and current approval status. We do not use outdated criteria. There is no universal CT schedule for everyone.

The Patient Journey

Key Questions in Plain Language

Frequently Asked Questions (FAQ)

Related Topics

Scientific References

1. Ljungberg B, et al. European Association of Urology Guidelines on Renal Cell Carcinoma. Eur Urol. 2022;82(4):399–410.
2. Marconi L, Kuusk T, Hora M, et al. Hospital Volume as a Determinant of Outcomes After Partial Nephrectomy: A Systematic Review by the EAU Renal Cell Carcinoma Guidelines Panel. Eur Urol Oncol. 2025;8(3):616–622.
3. Choueiri TK, et al. Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma (KEYNOTE-564). N Engl J Med. 2021;385(8):683–694.
4. Choueiri TK, et al. Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma. N Engl J Med. 2024;390(15):1359–1371.

Surgical Team

Laparoscopic partial nephrectomy is performed in collaboration with a specialised surgical centre and urology team, ensuring access to modern laparoscopic equipment.